Age-related paraoxonase activity changes in Turkish population

Annals of the New York Academy of Sciences

Volumn 1100, Issue , 2007, Pages 218-222

  Saruhan, Ercan ^a   Olgun, Abdullah ^a   Öztürk, Kamile ^a   Akman, Serif ^a   Erbil, M Kemal ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Aging; Arylesterase; HDL; Oxidative stress; Paraoxonase

Indexed keywords

ARYLDIALKYLPHOSPHATASE; ARYLESTERASE; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; ORGANOPHOSPHATE; OXYGEN;

ADULT; AGED; AGING; ATHEROGENESIS; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONFERENCE PAPER; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; GENETIC POLYMORPHISM; HUMAN; LIPID OXIDATION; MALE; MIDDLE AGED; NORMAL HUMAN; PHENOTYPE; POPULATION RESEARCH; PREVALENCE; STATISTICAL SIGNIFICANCE; TURKEY (REPUBLIC); ARTICLE; ATHEROSCLEROSIS; BIOSYNTHESIS; CHEMISTRY; METABOLISM;

ADULT; AGED; AGED, 80 AND OVER; AGING; ARYLDIALKYLPHOSPHATASE; ATHEROSCLEROSIS; CHOLESTEROL; FEMALE; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OXYGEN; PHOSPHORIC ACID ESTERS; TURKEY;

EID: 34249709853     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1395.022     Document Type: Conference Paper

References (8)

1. SMITH, B.L., J.A. MARTIN & S.J. VENTURA. 1999. Births and deaths: preliminary data for July 1997-June 1998. Natl. Vital Stat. Rep. 47: 1-32.
2. DURRINGTON, P.N., B. MACKNESS, & M.I. MACKNESS. 2001. Paraoxonase and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 21: 473-480.
3. AVIRAM, M., M. ROSENBLAT, C.L. BISGAIER, et al. 1998. Paraoxonase inhibits high density lipoprotein oxidation and preserves its function: a possible peroxidative role for paraoxonase. J. Clin. Invest. 101: 1581-1590.
4. IKEDA, Y., T. SUEHIRO, M. INOUE, et al. 1998. Serum paraoxonase activity and its relationship to diabetic complications in patients with non-insulin dependent diabetes mellitus. Metabolism 47: 598-602.
5. CHARLTON-MENYS, V., Y. LIU & P.N. DURRINGTON. 2006. Semiautomated method for determination of serum paraoxonase activity using paraoxon as substrate. Clin. Chem. 52: 453-457.
6. ECKERSON, H.W., J. ROMSON, C. WYTE & B.N. LA DU. 1983. The human serum paraoxonase polymorphism: identification of phenotypes by their response to salts. Am. J. Hum. Genet. 35: 214-227.
7. SMOLEN, A., H.W. ECKERSON, K.N. GAN, et al. 1991. Characteristics of the genetically determined allozymic forms of human serum paraoxonase/arylesterase. Drug Metab. Dispos. 19: 107-112.
8. KARAKAYA, A., S. IBIS, T. KURAL, et al. 1999. Serum paraoxonase activity and phenotype distribution in Turkish subjects with coronary heart disease and its relationship to serum lipids and lipoproteins. Chem. Biol. Interact. 118: 193-200.